Results 1 to 10 of about 92,159 (303)

Hyperactivity induced by injection of dopamine into the accumbens nucleus: Actions and interactions of neuroleptic, cholinomimetic and cholinolytic agents

Neuropharmacology, 1979
B Costall, S C Hui, R J Naylor
exaly  

Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

Chemical Reviews, 2013
Na Ye, John L Neumeyer, Ross J Baldessarini   +2 more
exaly  

Dopamine‐Melanin Colloidal Nanospheres: An Efficient Near‐Infrared Photothermal Therapeutic Agent for In Vivo Cancer Therapy

Advanced Materials, 2013
Yanlan Liu, Kelong Ai, Jianhua Liu
exaly  

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease

Annals of Neurology, 2003
Anthony H V, Schapira, C Warren, Olanow
openaire   +2 more sources

Human serum albumin and other proteins as templating agents for the synthesis of nanosized dopamine-eumelanin

Journal of Colloid and Interface Science, 2014
Vincent Ball
exaly  

Effects of recent and reference antipsychotic agents at human dopamine D 2 and D 3 receptor signaling in Chinese hamster ovary cells

Psychopharmacology, 2000
Mirek Jurzak, Josée E Leysen
exaly  

Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157

Journal of Physiology (Paris), 2000
Predrag Sikiric, Jadranka Separovic, Gojko Buljat   +2 more
exaly  

Dopamine-β-hydroxylase in cerebrospinal fluid and plasma: Effects of α-adrenergic agents

Brain Research, 1980
Leslie F Major, P Lerner
exaly  

Dopamine agonists show potential as antihypertensive agents

InPharma, 1987
openaire   +1 more source

Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole

Journal of Neurochemistry, 2003
Roberto Maggio, Marco Scarselli, Francesca Novi   +2 more
exaly